Comparing intralesional vitamin D3 with cryotherapy and cryotherapy alone in warts

Comparing the effectiveness of intralesional vitamin D3 plus cryotherapy versus monotherapy of cryotherapy among patients with cutaneous warts

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20230124057201N3

Enrollment

Registered

2023-07-09

Start date

2023-08-23

Completion date

Unknown

Last updated

2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cutaneous warts. Plantar wart

Interventions

Intervention 1: Intervention group: intralesional vitamin D3 plus cryotherapy. Intervention 2: Intervention group: monotherapy of cryotherapy.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients aged more than 18 Various cutaneous warts except in anogenital, facial and oral areas

Exclusion criteria

Exclusion criteria: Any type of inflammatory skin disease Any types of rheumatological and malignant disease Kidney and liver disease, eczema and diabetes Previous history of allergy to vitamin D3 Acquired immunodeficiency Pregnancy and lactation

Design outcomes

Primary

Measure	Time frame
Effectiveness of intralesional vitamin D3 and cryotherapy based on the size of the warts. Timepoint: every treatment sessions (sessions 1 to 4). Method of measurement: Ruler graded in millimeters.	—

Secondary

Measure	Time frame
Effectiveness of the treatments based on patient's satisfaction. Timepoint: After the end of the treatment. Method of measurement: Questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZeinab Aryanian

Tehran University of Medical Sciences

z_aryanian@yahoo.com+98 21 5563 0853

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026